Aspen Aerogels, Inc.
NYSE:ASPNConstruction
+$0.24 today
- Market cap
- $407.33M
- Beta
- 2.99
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$1.35
Volume 1.17M
Average 1.58M
ASPN Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Aspen Aerogels, Inc.NYSE: ASPN
Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Financing cash flow declines year over year
Q1 FY2026 financing cash flow of $15.77M (cash outflow) fell 26.6% year over year, ahead of the -155.0% change in trailing-twelve-month financing cash flow. Sequentially, it rose 109.3% from the prior quarter.
Context
- Financing cash flow amounted to 21.4% of revenue in FY2025, down 5.5 pp from a year earlier.
- Financing cash flow increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -26.6% holds above the trailing-twelve-month pace of -155.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (58.13M) USD
- Year-over-year change
- -147.6%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (58.13M) | -147.6% |
| FY2024 | 2024-12-31 | 122.02M | +61.7% |
| FY2023 | 2023-12-31 | 75.48M | -84.2% |
| FY2022 | 2022-12-31 | 478.37M | +417.3% |
| FY2021 | 2021-12-31 | 92.47M | — |
Financing Cash Flow vs competitors
How ASPN compares with its peers on the latest reported figures
- Peers report in different currencies, so financing cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -155.0% is the 8th highest of 9, against a peer median of -32.3%.
- Financing cash flow amounts to 22.8% of revenue for ASPN, versus a peer median of 17.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $1.46B USD | +662.5% | +109.0% | 245.1% | |
| LTM Dec 2025 | CN¥367.08M CNY | — | +50.9% | 87.8% | |
| LTM Mar 2026 | $174.51M USD | +337.3% | +152.7% | — | |
| LTM Feb 2026 | $96.18M USD | -165.9% | +1.9% | 6.8% | |
| LTM Apr 2026 | $87.4M USD | -123.2% | +40.6% | 4.7% | |
| LTM Mar 2026 | $57.16M USD | -27.4% | +333.8% | 27.2% | |
| LTM Mar 2026 | $52.42M USD | -155.0% | — | 22.8% | |
| LTM Apr 2026 | $48.59M USD | -37.2% | -11.9% | 1.6% | |
| FY2025 | €35.07M EUR | +230.9% | — | 111.1% | |
| LTM Mar 2026 | $25.4M USD | -41.9% | -58.1% | 0.7% | |
| Peer median (excluding ASPN) | — | -32.3% | +45.8% | 17.0% | |
Competitors are the stored peer set for ASPN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (37.09M) | (82.74M) | (45.81M) | 13.38M | (389.55M) |
| Depreciation & Amortization | 9.44M | 9.22M | 18.18M | 22.53M | 45.16M |
| Deferred Income Tax | (3.82M) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 5.18M | 9.39M | 10.95M | 12.86M | 8.63M |
| Change in Working Capital | 6.03M | (38.17M) | (31.17M) | (50.96M) | 48.56M |
| Accounts Receivables | (4.64M) | (37.04M) | (12.55M) | (39.36M) | 70.3M |
| Inventory | 1.11M | (10.55M) | (16.65M) | (8.36M) | 9.3M |
| Accounts Payables | 7.38M | 5.32M | 4.58M | 7.34M | (19.45M) |
| Other Working Capital | 2.19M | 4.11M | (6.55M) | (10.58M) | (11.59M) |
| Other Non-Cash Items | 1.64M | 7.9M | 16.19M | 47.75M | 320.08M |
| Operating Cash Flow | (18.63M) | (94.4M) | (42.61M) | 45.55M | 32.87M |
| Capital Expenditures | (13.78M) | (177.97M) | (175.46M) | (86.26M) | (37.45M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (13.78M) | (177.97M) | (175.46M) | (86.26M) | (37.45M) |
| Debt Repayment | 0 | 100M | (623K) | 25.59M | (59.23M) |
| Common Stock Issued | 94.42M | 391.3M | 76.52M | 93.84M | 1.87M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (1.95M) | (12.93M) | (420K) | 2.59M | (765K) |
| Financing Cash Flow | 92.47M | 478.37M | 75.48M | 122.02M | (58.13M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 60.07M | 206M | (142.59M) | 81.31M | (62.71M) |
| Free Cash Flow | (32.41M) | (272.37M) | (218.07M) | (40.71M) | (4.58M) |
Aspen Aerogels, Inc.
NYSE:ASPN
Intrinsic Alpha fair value
Locked
Current Price
$4.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.